Answer
Its UK licence requires no known mutations associated with resistance to integrase inhibitors, emtricitabine or tenofovir. Treatment history and resistance results should be reviewed.
Sources for this answer
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead 90 mg/90 mg/120 mg/6 mg film coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.